Dr. Bertram Pitt and Dr. C. Michael Gibson Discuss: FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes August 28, 2021 Disclosures: TBD
Dr. Marco Valgimigli and Dr. C. Michael Gibson Discuss: MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients August 28, 2021 Disclosures: TBD
Dr. George Dangas and Dr. C. Michael Gibson Discuss: ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation August 28, 2021 Disclosures: TBD
Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: ESC 2021 Wrap-Up – Friday, August 27 August 27, 2021 Disclosures: TBD
Dr. Axel Bauer and Dr. Yaz Daaboul Discuss: Implantable cardiac monitors in high-risk post-infarction patients with cardiac autonomic dysfunction and moderately reduced left ventricular ejection fraction – A randomized trial August 27, 2021 Disclosures: TBD
Dr. Stefan Anker and Dr. C. Michael Gibson Discuss: EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalizations in patients with heart failure with a preserved ejection fraction, with and without diabetes August 27, 2021 Disclosures: TBD
Dr. Burkert Pieske and Dr. C. Michael Gibson Discuss: PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF September 1, 2020
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19 September 1, 2020 Disclosures: TBD
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss: ESC 2020 With a Focus This Year on Advances in Heart Failure and Renal Failure September 1, 2020
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: Changes to the NSTEMI guidelines and Popular TAVI September 1, 2020
